Jessica Chubak to Mass Screening
This is a "connection" page, showing publications Jessica Chubak has written about Mass Screening.
Connection Strength
2.563
-
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium. J Gen Intern Med. 2026 05; 41(7):1761-1770.
Score: 0.620
-
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
Score: 0.317
-
Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2015 Jun; 22(2):69-75.
Score: 0.293
-
Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010 Sep; 48(9):815-20.
Score: 0.218
-
Global impact of COVID-19 on organized CRC screening programs: lessons learned. Best Pract Res Clin Gastroenterol. 2026 Feb; 80:102047.
Score: 0.154
-
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
Score: 0.128
-
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520.
Score: 0.124
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
Score: 0.088
-
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15.
Score: 0.080
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.076
-
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
Score: 0.065
-
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
Score: 0.065
-
Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7.
Score: 0.061
-
Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603.
Score: 0.054
-
Optimal Stopping Ages for Colorectal Cancer Screening. JAMA Netw Open. 2024 Dec 02; 7(12):e2451715.
Score: 0.037
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
Score: 0.032
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
Score: 0.031
-
Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
Score: 0.031
-
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
Score: 0.031
-
Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75.
Score: 0.020
-
Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
Score: 0.019
-
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95.
Score: 0.018